Neonatal Cholestasis: A Narrative Review of the Working Group of the Latin American Society of Pediatric Gastroenterology, Hepatology and Nutrition

Authors

  • Marcela Godoy Hospital Clínico San Borja Arriaran. Santiago de Chile. Chile. https://orcid.org/0000-0002-6467-953X
  • Carola López Centro Hospitalario Pereira Rossell. Montevideo. Uruguay. https://orcid.org/0000-0001-6167-0444
  • Felipe Álvarez Chavez Hospital de Pediatría, Centro Médico Nacional de Occidente, IMSS. Guadalajara, Jalisco. México. https://orcid.org/0000-0002-5087-3075
  • Raquel Borges Pinto Hospital da Criança Conceição do Grupo Hospitalar Conceição. Porto Alegre, Rio Grande do Sul. Brasil. https://orcid.org/0000-0002-5521-7528
  • Verónica Botero Osorio Unidad de Trasplantes Fundación Valle de Lili. Cali. Colombia https://orcid.org/0000-0001-8855-075X
  • María Valentina Dolz Aguilar Hospital de Carabineros y Clínica Las Condes. Santiago de Chile. Chile. https://orcid.org/0000-0001-8820-8946
  • Michelle Higuera Hospital San José Infantil. Bogotá. Colombia. https://orcid.org/0000-0002-0876-7885
  • Reynaldo de Jesús Michel Aceves Hospital Central Militar. Ciudad de México. México. https://orcid.org/0000-0002-6614-7529
  • Gloria Rios Marcuello Clínica Alemana de Santiago, Facultad de Medicina Clínica Alemana. Universidad del Desarrollo. Santiago de Chile. Chile. https://orcid.org/0000-0002-6108-4784
  • Lorena Rodríguez González Hospital San Juan de Dios y Clínica Alemana de Santiago. Santiago de Chile. Chile https://orcid.org/0000-0001-6125-2920
  • Claudia Rojo Lillo Hospital Regional de Antofagasta y Universidad de Antofagasta. Antofagasta. Chile.
  • Humberto E Soriano Departamento de Gastroenterología y Nutrición Pediátrica. Pontificia Universidad Católica de Chile. Santiago de Chile. Chile.
  • Mirta Ciocca Hospital Alemán. Buenos Aires. Argentina. https://orcid.org/0000-0001-7232-7529

DOI:

https://doi.org/10.52787/agl.v52i3.134

Keywords:

Jaundice, neonatal cholestasis, biliary atresia

Abstract

Neonatal jaundice requires a differential diagnosis between unconjugated or indirect hyperbilirubinemia and direct or conjugated hyperbilirubinemia, characteristic of neonatal cholestasis, which is always pathological. It is recommended in all newborns of 15 days or older with jaundice to perform differential bilirubin to be able to detect it. Cholestasis is defined by direct bilirubin > 1 mg/dl (17 µmol/L) and its estimated frequency during the neonatal period is 1:2,500 live births.
The most frequent etiologies are infectious, genetic/metabolic, obstructive, endocrinological, toxic, immunological. The most common cause is biliary atresia, which is clinically manifested by jaundice and acholia, so in patients with these signs that diagnosis should always be considered as the first option to rule out. An early diagnosis of neonatal cholestasis is essential to optimize management of treatable causes and improve prognosis. Unfortunately, diagnosis is not always early. That is why the Working Group of the Latin American Society of Pediatric Gastroenterology, Hepatology and Nutrition carried out this review of diagnosis, treatment and follow-up of neonatal cholestasis, whose objective is to provide a useful tool that allows early diagnosis and improves the prognosis of children with neonatal cholestasis.

References

-1. Lane E, Murray KF. Neonatal Cholestasis. Pediatr Clin North Am. 2017;64(3):621-39.

-2. Fawaz R, Baumann U, Ekong U, Fischler B, Hadzic N, Mack CL, McLin VA, Molleston JP, Neimark E, Ng VL, Karpen SJ. Guideline for the Evaluation of Cholestatic Jaundice in Infants: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2017;64(1):154-68.

-3. Feldman AG, Sokol RJ. Recent developments in diagnostics and treatment of neonatal cholestasis. Semin Pediatr Surg.,2020; 29(4):150945.

-4. Ananth R. Neonatal Cholestasis: A Primer of Selected Etiologies. Pediatr Ann. 2018;47(11):e433-39.

-5. Cassoti V, D’Antiga. Liver disease in paedriatric medicine: An overview. In: D’Antiga L. Pediatric Hepatology and liver transplantation. Cham, Switzerland: Springer Nature Switzerland. 2019:3-19.

-6. Götze T, Blessing H, Grillhösl C, Gerner P, Hoeming A. Neonatal cholestasis – differential diagnoses, current diagnostic procedures, and treatment. Front. Pediatr. 2015;3(43):1-10.

-7. D’Amato M, Ruiz P, Aguirre K, Gómez S. Cholestasis in Pediatrics. Rev Col Gastroenterol. 2016;31(4):409-17.

-8. Verkade HJ, Bezerra JA, Davenport M, Schreiber RA, Mieli-Vergani G, Hulscher JB, Sokol RJ, Kelly DA, Ure B, Whitington PF, Samyn M, Petersen C. Biliary atresia and other cholestatic childhood diseases: Advances and future challenges. J Hepatol. 2016;65(3):631-42.

-9. Schreiber RA: Newborn Screening for Biliary Atresia. JAMA. 2020;323(12):1137-8.

-10. Jiang J, Wang J, Shen Z, Lu X, Chen G, Huang Y, Dong R, Zheng S. Serum MMP-7 in the Diagnosis of Biliary Atresia. Pediatrics. 2019;144(5):1-9.

-11. Yang L, Zhou Y, Xu P, Mourya R, Lei H, Cao G, Xiong X, Xu H, Duan X, Wang N, Fei L, Chang X, Zhang X, Jiang M, Bezerra JA, Tang S. Diagnostic Accuracy of Serum Matrix Metalloproteinase-7 for Biliary Atresia. Hepatology. 2018;68:2069-77.

-12. Gu YH, Yokoyama K, Mizuta K, Tsuchioka T, Kudo T, Sasaki H, Nio M, Tang J, Ohkubo T, Matsui A. Stool color card screening for early detection of biliary atresia and long-term native liver survival: a 19-year cohort study in Japan. J Pediatr, 2015;166:897-902.

-13. Wolfson JP, Shereiber RA, Butler AE, MacFarlane J, Kaczorowski J, Masucci L, Bryan S, Collet JP. Province wide Biliary Atresia Home screen Program In British Columbia: Evaluation of first 2 years. J Ped Gastroenterol Nutr. 2018;66:845-49.

-14. Mogul D, Zhou M, Intihar P, Schwarz K, Frock K. Cost Effective Analysis for Screening for Biliary Atresia With the Stool Color Card. J Ped Gastroenterol Nutr. 2015;60:91-8.

-15. Borgeat M, Korff S, Wildhaber BE. Newborn biliary atresia screening with the stool colour card. BMJ Paediatr Open. 2018;2(1):e000269.

-16. Martin M, Holmes S, Sim J, Hassan M, Mathew R, Bensen R, Barakat M. Foregone Inclusion: Neonatal CMV Hepatitis and Cholestasis. Dig Dis Sci. 2019;64(11): 3092-5.

-17. Comité Nacional de Hepatología Pediátrica de la Sociedad Argentina de Pediatría. Consenso de hiperbilirrubinemia del primer trimestre de la vida. Arch Argent Pediatr. 2020;118(1):S12-S49.

-18. Strnad P, McElvaney NG, Lomas DA. Alpha 1- Antitrypisin Deficiency. N Engl J Med. 2020;382(15):1443-55. 19. Cakir M, Sag E, Islek A, Baran M, Tumgor G, Aydogdu S. Liver Involvement in Children whith Alpha-1 Antitrypisin Deficiency: A Multicenter Study. Pediatr Gastroenterol Hepatol Nutr. 2020;23(2):146-53.

-20. Feldman AG, Sokol RJ. Neonatal cholestasis: emerging molecular diagnostics and potential novel therapeutics. Nat Rev Gastroenterol Hepatol. 2019;16(6):346-60.

-21. Chen HL, Wu SH, Hsu SH, Liou BY, Chen HL, Chang MH. Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases. J Biomed Sci. 2018;25(1):75.

-22. Mandato C, Zollo G, Vajro P. Cholestatic jaundice in infancy: struggling with many old and new phenotypes. Ital J Pediatr. 2019;45:83.

-23. Nicastro E, Di Giorgio A, Marchetti D, Barboni Ch, Cereda A, Iascone M, D’Antiga L. Diagnostic Yield of an Algorithm for Neonatal and Infantile Cholestasis Integrating Next-Generation Sequencing. J Pediatr. 2019;211:54-62.

-24. Togawa T, Sugiura T, Ito K, Endo T, Aoyama K, Ohashi K, Negishi Y, Kudo T, Ito R, Kikuchi A, Arai-Ichinoi N, Kure S, Saitoh S. Molecular Genetic Dissection and Neonatal/Infantile Intrahepatic Cholestasis Using Targeted Next-Generation Sequencing. J Pediatr. 2016;171:171-7.

-25. Kamath BM, Baker A, Houwen R, Todorova L, Kerkar N. Systematic Review: The Epidemiology, Nature History and Burden of Alagille Syndrome. J Pediatr Gastroenterol Nutr. 2018;67(2):148-56.

-26. Henkel SA, Squires JH, Ayers M, Ganoza A, Mckiernan P, Squires JE. Expanding etiology of progressive familial intrahepatic cholestasis. World J Hepatol. 2019;11(5):450-63.

-27. Seung Hwan B, Ji-Man K, Kyong I, Seok Joo H, Hong K, Jong Gyun A. The Epidemiology and Etiology of Cholangitis After Kasai Portoenterostomy in Patients with Biliary Atresia. J Pediatr Gastroentrol Nutr. 2020;70:171-7.

-28. Sintusek P, Siriporn N, Punpanich D, Chongsrisawat V, Poovorawan Y. Spleen and Liver Stiffness to Detect Esophageal Varices in Children with Biliary Atresia. J Pediatr Gastroenterol Nutr. 2019;69(4):411-5.

-29. Snehavardhan P, Khanna R, Lal BB, Sood V, Sood AK, Alam S. Comparison of Two Diagnostic Criteria for Hepatopulmonary Syndrome–High Prevalence in Biliary Atresia. J Pediatr Gastroentrol Nutr. 2020;70:623-7.

-30. Khanna R, Verma SK. Pediatric hepatocellular carcinoma. World J Gastroenterol. 2018;24(35):3980-99.

-31. Miller K., Leake K., Sharma T. Advances in vaccinating immunocompomised children. Curr Opin Pediatr. 2020;32(1):145-50.

-32. Feldman AG, Sokol RJ. Neonatal cholestasis: emerging molecular diagnostics and potential novel therapeutics. Nat Rev Gastroenterol Hepatol. 2019;16:346-60.

-33. Sanchez P, Farkhondeh A, Pavlinov I, Baumgaertel K, Rodems S, Zheng W. Therapeutics Development for Alagille Syndrome. Front. Pharmacol. 23 de Agosto de 2021 | https://doi.org/10.3389/fphar.2021.704586

-34. Deeks ED. Odevixibat: First Approval. Drugs. 2021;81:1781-6.

Published

2022-09-29

How to Cite

Godoy, M., López, C., Álvarez Chavez, F., Borges Pinto, R., Botero Osorio, V., Dolz Aguilar, M. V., Higuera, M., Michel Aceves, R. de J., Rios Marcuello, G., Rodríguez González, L., Rojo Lillo, C., Soriano, H. E., & Ciocca, M. (2022). Neonatal Cholestasis: A Narrative Review of the Working Group of the Latin American Society of Pediatric Gastroenterology, Hepatology and Nutrition. Acta Gastroenterológica Latinoamericana, 52(3), 344–354. https://doi.org/10.52787/agl.v52i3.134